Advent Venture backs MetaPhore

The UK IT and life sciences investor has made its third investment in as many weeks as part of a $30m investment in the US pharmaceuticals firm.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this